RsaI polymorphism of the ERβgene in women with endometriosis

article OA: bronze CC0 ⤵ 15 in-corpus citations
AI-generated summary by claude@2026-06, 2026-06-08

This study found that the heterozygous AG genotype of the RsaI polymorphism in the ERβ gene was significantly more frequent in women with endometriosis compared to controls.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

We examined the frequency of RsaI polymorphism of the ERβ gene in 54 patients diagnosed with endometriosis and 46 controls. Peripheral blood was collected from women undergoing laparoscopy with a confirmed diagnosis of endometriosis. Polymorphisms of the ERβ gene and p53 were assessed by PCR and analyzed on 2% agarose gel stained with ethidium bromide. The AG polymorphism genotype frequency in patients with endometriosis was 59.3%, with 40.7% GG. In the control group, the frequency of AG was 6.5%, with 93.5% GG. The frequency of heterozygous AG was nine times higher in patients with endometriosis than in the control group (P < 0.0001).

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Deoxyribonucleases, Type II Site-Specific Endometriosis Estrogen Receptor beta Polymorphism, Genetic Adult Deoxyribonucleases, Type II Site-Specific Endometriosis Endometriosis Estrogen Receptor beta Estrogen Receptor beta Female Humans

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (17)

Cited by (15)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:16:48.482574+00:00
License: CC0 · commercial use OK